Zobrazeno 1 - 10
of 3 412
pro vyhledávání: '"PMS2"'
Autor:
Magalhães IA; Departamento de Odontologia, Unichristus, Fortaleza, Ceará, Brazil., Costa GAJ; Departamento de Odontologia, Unichristus, Fortaleza, Ceará, Brazil., Crispim AA; ICC Genomics, Hospital Haroldo Juaçaba, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil., Dantas TS; Departamento de Odontologia, Unichristus, Fortaleza, Ceará, Brazil., Sousa FB; Departamento de Odontologia, Unichristus, Fortaleza, Ceará, Brazil., Bezerra MJB; ICC Genomics, Hospital Haroldo Juaçaba, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil., Silva PGB; Departamento de Odontologia, Unichristus, Fortaleza, Ceará, Brazil.; ICC Genomics, Hospital Haroldo Juaçaba, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
Publikováno v:
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology [J Oral Pathol Med] 2024 Nov; Vol. 53 (10), pp. 637-647. Date of Electronic Publication: 2024 Oct 03.
Autor:
Segura AVC; Clinical and Functional Genomics Group, International Research Center/CIPE, A.C.Camargo Cancer Center, 440 Taguá St, São Paulo, SP, 01508-010, Brazil., da Silva SIO; Clinical and Functional Genomics Group, International Research Center/CIPE, A.C.Camargo Cancer Center, 440 Taguá St, São Paulo, SP, 01508-010, Brazil., Santiago KM; Clinical and Functional Genomics Group, International Research Center/CIPE, A.C.Camargo Cancer Center, 440 Taguá St, São Paulo, SP, 01508-010, Brazil., Brianese RC; Clinical and Functional Genomics Group, International Research Center/CIPE, A.C.Camargo Cancer Center, 440 Taguá St, São Paulo, SP, 01508-010, Brazil., Carraro DM; Clinical and Functional Genomics Group, International Research Center/CIPE, A.C.Camargo Cancer Center, 440 Taguá St, São Paulo, SP, 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo, Brazil., Torrezan GT; Clinical and Functional Genomics Group, International Research Center/CIPE, A.C.Camargo Cancer Center, 440 Taguá St, São Paulo, SP, 01508-010, Brazil. giovana.torrezan@accamargo.org.br.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo, Brazil. giovana.torrezan@accamargo.org.br.
Publikováno v:
Familial cancer [Fam Cancer] 2024 Nov; Vol. 23 (4), pp. 653-657. Date of Electronic Publication: 2024 Jun 20.
Autor:
Panyavaranant P; Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Pohthipornthawat N; Department of Obstetrics and Gynecology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Manchana T; Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Oct 01; Vol. 25 (10), pp. 3667-3671. Date of Electronic Publication: 2024 Oct 01.
Autor:
Vink-Börger E; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., den Bakker M; Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands., Voorham R; Palga Foundation, Houten, The Netherlands., van Nederveen F; Laboratory for Pathology (PAL), Dordrecht, The Netherlands., Nagtegaal I; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.
Publikováno v:
Histopathology [Histopathology] 2024 Oct; Vol. 85 (4), pp. 639-648. Date of Electronic Publication: 2024 Jun 11.
Autor:
Mistry NA; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Roellinger SE; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Manninen MC; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Gandham M; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Koganti T; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Balan J; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Basu S; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Blake EJ; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Tandale PP; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Holdren MA; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Hoenig MF; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Urban RM; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Veith RL; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kendzior MC; Department of Information Technology, Mayo Clinic, Rochester, Minnesota., Wang C; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Gupta S; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Shen W; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: shen.wei@mayo.edu.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2024 Sep; Vol. 26 (9), pp. 843-850. Date of Electronic Publication: 2024 Jun 24.
Autor:
Matoy EJ; Department of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68178, USA., Plowman JN; Department of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68178, USA., Watson CJ; Creighton University Core Facilities, Creighton University, Omaha, NE 68178, USA., Belshan MA; Department of Medical Microbiology and Immunology, Creighton University, Omaha, NE 68178, USA., Blue EE; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, WA 98195, USA; Institute for Public Health Genetics, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute, Seattle, WA 98195, USA., Huff CD; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Stessman HAF; Department of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68178, USA; Creighton University Core Facilities, Creighton University, Omaha, NE 68178, USA. Electronic address: hollystessman@creighton.edu.
Publikováno v:
HGG advances [HGG Adv] 2024 Jul 18; Vol. 5 (3), pp. 100298. Date of Electronic Publication: 2024 Apr 22.
Autor:
Maraqa B; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Al-Ashhab M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Zughaier H; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Barakat F; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Khader M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Al Maaitah H; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Alabweh R; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Sughayer M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan.
Publikováno v:
The Journal of international medical research [J Int Med Res] 2024 Jun; Vol. 52 (6), pp. 3000605241259747.
Autor:
Munté E; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain., Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain; Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain., Del Valle J; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain; Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain., González S; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain., Ramos-Muntada M; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain; Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain., Balmaña J; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Medical Oncology Department, University Hospital of Vall d'Hebron, Barcelona, Spain., Ramon Y Cajal T; Familial Cancer Clinic, Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain., Tuset N; Medical Oncology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Llort G; Department of Medical Oncology Parc Taulí, Hospital Universitari Parc Taulí Sabadell, Barcelona, Spain., Cadiñanos J; R&D Laboratory, Fundación Centro Médico de Asturias-IMOMA, Oviedo, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain; Precision Oncology Group (OncoGir_Pro), Institut d'Investigació Biomèdica de Girona, Girona, Spain., Capellá G; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain; Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain., Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain; Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain. Electronic address: clazaro@iconcologia.net., Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain; Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain. Electronic address: mpineda@iconcologia.net.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2024 Aug; Vol. 26 (8), pp. 727-738. Date of Electronic Publication: 2024 Jun 06.
Autor:
Genç DB; University of Health Sciences Türkiye, Şişli Hamidiye Etfal Training and Research Hospital, Department of Pediatric Hematology and Oncology, İstanbul, Türkiye, Yıldırmak ZY; University of Health Sciences Türkiye, Şişli Hamidiye Etfal Training and Research Hospital, Department of Pediatric Hematology and Oncology, İstanbul, Türkiye, Elli M; İstanbul Medipol University Faculty of Medicine, Department of Pediatric Oncology, İstanbul, Türkiye, Ayaz A; İstanbul Medipol University Faculty of Medicine, Department of Medical Genetics, İstanbul, Türkiye, Ton Ö; University of Health Sciences Türkiye, Şişli Hamidiye Etfal Training and Research Hospital, Department of Pathology, İstanbul, Türkiye
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 May 30; Vol. 41 (2), pp. 126-127. Date of Electronic Publication: 2024 Mar 01.
Autor:
Marín F; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain., Canet-Hermida J; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain., Bianchi V; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Chung J; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Wimmer K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Foulkes W; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.; Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Pérez-Alonso V; Department of Pediatric Hematology and Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), Madrid, Spain., Domínguez-Pinilla N; Department of Pediatric Hematology and Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), Madrid, Spain., Sábado C; Department of Pediatric Hematology and Oncology, Hospital Vall d'Hebron, Barcelona, Spain., Vázquez-Gómez F; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Molinés A; Hematology and Hemotherapy Unit, Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria, Spain., Fioravantti V; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Carrasco E; Hereditary Cancer Genetics Group, Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Stengs L; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Edwards M; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Negm L; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Das A; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Pediatrics, University of Toronto, Toronto, ON, Canada., Aronson M; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada., Pastor Á; Laboratorio de Cáncer Hereditario, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 Octubre (i+12), Madrid, Spain., Rueda D; Laboratorio de Cáncer Hereditario, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 Octubre (i+12), Madrid, Spain., González-Granado LI; Immunodeficiencies Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 Octubre (i+12), Madrid, Spain., Tabori U; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada., Capellá G; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Hereditary Cancer Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Pineda M; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Hereditary Cancer Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Publikováno v:
Clinical chemistry [Clin Chem] 2024 May 02; Vol. 70 (5), pp. 737-746.